Results 131 to 140 of about 1,470 (198)

The B-cells paradigm in Systemic Sclerosis: an update on pathophysiology and B-cell targeted therapies [PDF]

Annunziato, Francesco, Bellando Randone, Silvia, Di Pietro, Linda, Matucci Cerinic, Marco, Scaletti, Cristina   +4 more
core   +1 more source

Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus. [PDF]

Front Neurol
Tsokkos T, Strataki E, Tzavella D, Zamba-Papanicolaou E, Kleopa KA, Zouvelou V.   +5 more
europepmc   +1 more source

Real-World Outcomes of Efgartigimod in Adult Myasthenia Gravis. [PDF]

Cureus
Krall T, Byrne S, Kelbert J, Chrisman C.
europepmc   +1 more source

A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis. [PDF]

Curr Neuropharmacol
Ma C, Shen J, Zhu Y, Zhu R.
europepmc   +1 more source

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial. [PDF]

J Clin Neurol
Lin J, Ding M, Wang Q, Chang T, Zhao Y, Da Y, Tan S, Hong D, Jiang H, Zou Z, Yang H, Bu B, Liang H, Wang Y, Guo A, He D, Wang Y, Ding J, Guo J, Shi J, Zhang Y, Liu J, Liu J, Chen L, Wu J, Shao J, Hofman E, Hoorick BV, Mole T, Li W, Lu Z.   +30 more
europepmc   +1 more source

Usefulness of Early Treatment with Efgartigimod in Patients with Generalized Myasthenia Gravis Complicated by Cardiovascular Disease: A Case Report. [PDF]

Case Rep Neurol
Kawakita R, Deguchi K.
europepmc   +1 more source

Efficacy and safety of efgartigimod PH20 SC for Sjögren's disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study). [PDF]

Front Med (Lausanne)
Endo Y, Hosogaya N, Fukushige Y, Narita S, Jacobs J, Reiss W, Imai Y, Shimizu T, Koga T, Yamamoto H, Sakai T, Takagi Y, Sumi M, Kawakami A.   +13 more
europepmc   +1 more source

Neuromuscular Junction Disorders [PDF]

Barohn, Richard, Dimachkie, Mazen, Katz, Jonathan, Levine, Todd, Pasnoor, Mamatha, Saperstein, David, Wolfe, Gil   +6 more
core   +2 more sources

Case Report: Atypical anti-KLHL11 antibody encephalitis: recurrent staring spells, serial negative MRI findings, and a tripartite diagnostic journey. [PDF]

Front Immunol
Xie Y, Chen J, Xu W, Zhu Y, Zhou H, Cai T.   +5 more
europepmc   +1 more source

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications. [PDF]

Biomedicines
Mansour GK, Alangari L, Khosyfan L, Alhammad R, Hajjar AW.   +4 more
europepmc   +1 more source